Publication

Article

BioPharm International

BioPharm International-12-15-2019
Volume2019 eBook
Issue 5
Pages: 40–41

Regulatory and Standard Setting Organizations

Connect with pharmaceutical and healthcare regulatory authorities around the world via this directory.

Connect with pharmaceutical and healthcare regulatory authorities around the world via this directory.

 

Access these resources in BioPharm International’s December 2019 Regulatory Sourcebook.

 

Articles in this issue
BPebook1219_PharmacopeiaCompendia_PT6_225.jpg
Revision Process for Global/National Pharmacopoeias (eBook)
BPebook1219_PharmacopeiaCompendia_PT7__225.jpg
Surveillance Process for Industry: Monitoring Pharmacopoeia Revisions (eBook)
BPebook1219_RegulatoryUpdate_225.jpg
Warning Letters Signal Steps to Compliance
Lessons from FDA 483s and cGMP Inspection Data
BPebook1219_Resources_Guidelines_225.jpg
Resources, Guidelines, and Guidance Documents
BPebook1219_040-041_Resources_Organizations_225.jpg
Regulatory and Standard Setting Organizations

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!
Related Videos
Related Content
The front of the REGENXBIO facility in Rockville, Montgomery County, Maryland. REGENXBIO is a biotechnology company researching Adeno-Associate Virus (AAV) gene therapy | Image Credit: © MJ Kerr - stock.adobe.com
August 20th 2025

FDA Extends Review Period for REGENXBIO Hunter Syndrome Treatment

Patrick Lavery
Lung cancer, 3D illustration and photo under microscope. Histopathology light micrograph of small cell lung cancer | Image Credit: © Dr_Microbe - © Dr_Microbe - stock.adobe.com
August 20th 2025

Merck and Daiichi Sankyo’s I-DXd Earns FDA Breakthrough Therapy Status in Small Cell Lung Cancer

Feliza Mirasol
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
August 20th 2025

FDA Grants Breakthrough Therapy Designation to Bispecific ADC for EGFR-Mutant Lung Cancer

Feliza Mirasol
Human papillomavirus infection. Virus. HPV is the most common sexually transmitted infection globally. HPV infection is caused by human papillomavirus, a DNA virus from the papillomavirus family, 3d | Image Credit: © Naeblys - stock.adobe.com
August 20th 2025

FDA Approves Precigen’s Immunotherapy to Treat Recurrent Respiratory Papillomatosis

Patrick Lavery
Quality Control Laboratory medicine. Chromatograph operation. A woman makes an analysis on a gas chromatograph. Development of a new vaccine against the covid-19 virus. | Image Credit: © neznamov1984 - © neznamov1984 - stock.adobe.com
August 20th 2025

ElevateBio BaseCamp Achieves First Multi-Modality ICMC Certification in Commercial CGT Manufacturing

Feliza Mirasol
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
August 20th 2025

Celltrion Gains Expanded Indication Approval from FDA for its Actemra Biosimilar for CRS Therapy

Feliza Mirasol
© 2025 MJH Life Sciences

All rights reserved.